AR050121A1 - Derivados del acido acetico con sustituyentes ciclohexilmetoxi, procesos para su preparacion y su uso como medicamentos. - Google Patents
Derivados del acido acetico con sustituyentes ciclohexilmetoxi, procesos para su preparacion y su uso como medicamentos.Info
- Publication number
- AR050121A1 AR050121A1 ARP050103350A ARP050103350A AR050121A1 AR 050121 A1 AR050121 A1 AR 050121A1 AR P050103350 A ARP050103350 A AR P050103350A AR P050103350 A ARP050103350 A AR P050103350A AR 050121 A1 AR050121 A1 AR 050121A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- derivatives
- acetic acid
- ciclohexilmetoxi
- medications
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 150000001242 acetic acid derivatives Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039533A DE102004039533B4 (de) | 2004-08-14 | 2004-08-14 | Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050121A1 true AR050121A1 (es) | 2006-09-27 |
Family
ID=35376939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103350A AR050121A1 (es) | 2004-08-14 | 2005-08-11 | Derivados del acido acetico con sustituyentes ciclohexilmetoxi, procesos para su preparacion y su uso como medicamentos. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7538131B2 (https=) |
| EP (1) | EP1789402B1 (https=) |
| JP (1) | JP2008509894A (https=) |
| KR (1) | KR20070046116A (https=) |
| CN (1) | CN101014579A (https=) |
| AR (1) | AR050121A1 (https=) |
| AT (1) | ATE449086T1 (https=) |
| AU (1) | AU2005274495A1 (https=) |
| BR (1) | BRPI0514360A (https=) |
| CA (1) | CA2576584A1 (https=) |
| DE (2) | DE102004039533B4 (https=) |
| DK (1) | DK1789402T3 (https=) |
| ES (1) | ES2335513T3 (https=) |
| IL (1) | IL181011A0 (https=) |
| MX (1) | MX2007000846A (https=) |
| PA (1) | PA8641601A1 (https=) |
| PE (1) | PE20060643A1 (https=) |
| PT (1) | PT1789402E (https=) |
| TW (1) | TW200621733A (https=) |
| UY (1) | UY29064A1 (https=) |
| WO (1) | WO2006018118A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20040199A2 (en) * | 2001-08-31 | 2005-04-30 | Aventis Pharma Deutschland Gmbh | Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039533A patent/DE102004039533B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 KR KR1020077003579A patent/KR20070046116A/ko not_active Withdrawn
- 2005-07-30 DK DK05772372.8T patent/DK1789402T3/da active
- 2005-07-30 BR BRPI0514360-8A patent/BRPI0514360A/pt not_active IP Right Cessation
- 2005-07-30 AT AT05772372T patent/ATE449086T1/de not_active IP Right Cessation
- 2005-07-30 EP EP05772372A patent/EP1789402B1/de not_active Expired - Lifetime
- 2005-07-30 AU AU2005274495A patent/AU2005274495A1/en not_active Abandoned
- 2005-07-30 PT PT05772372T patent/PT1789402E/pt unknown
- 2005-07-30 ES ES05772372T patent/ES2335513T3/es not_active Expired - Lifetime
- 2005-07-30 CN CNA2005800271483A patent/CN101014579A/zh active Pending
- 2005-07-30 MX MX2007000846A patent/MX2007000846A/es active IP Right Grant
- 2005-07-30 CA CA002576584A patent/CA2576584A1/en not_active Abandoned
- 2005-07-30 DE DE502005008552T patent/DE502005008552D1/de not_active Expired - Lifetime
- 2005-07-30 WO PCT/EP2005/008284 patent/WO2006018118A1/de not_active Ceased
- 2005-07-30 JP JP2007525218A patent/JP2008509894A/ja not_active Abandoned
- 2005-08-10 PE PE2005000925A patent/PE20060643A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127241A patent/TW200621733A/zh unknown
- 2005-08-11 AR ARP050103350A patent/AR050121A1/es not_active Application Discontinuation
- 2005-08-12 PA PA20058641601A patent/PA8641601A1/es unknown
- 2005-08-12 UY UY29064A patent/UY29064A1/es unknown
-
2007
- 2007-01-28 IL IL181011A patent/IL181011A0/en unknown
- 2007-02-02 US US11/670,594 patent/US7538131B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007000846A (es) | 2007-04-17 |
| WO2006018118A1 (de) | 2006-02-23 |
| AU2005274495A1 (en) | 2006-02-23 |
| ES2335513T3 (es) | 2010-03-29 |
| KR20070046116A (ko) | 2007-05-02 |
| ATE449086T1 (de) | 2009-12-15 |
| UY29064A1 (es) | 2006-02-24 |
| US7538131B2 (en) | 2009-05-26 |
| DE102004039533B4 (de) | 2006-09-28 |
| BRPI0514360A (pt) | 2008-07-15 |
| PT1789402E (pt) | 2010-02-01 |
| WO2006018118A8 (de) | 2006-05-18 |
| DE502005008552D1 (de) | 2009-12-31 |
| US20070197612A1 (en) | 2007-08-23 |
| CA2576584A1 (en) | 2006-02-23 |
| DE102004039533A1 (de) | 2006-03-02 |
| DK1789402T3 (da) | 2010-03-22 |
| TW200621733A (en) | 2006-07-01 |
| CN101014579A (zh) | 2007-08-08 |
| JP2008509894A (ja) | 2008-04-03 |
| PE20060643A1 (es) | 2006-07-26 |
| IL181011A0 (en) | 2007-07-04 |
| EP1789402A1 (de) | 2007-05-30 |
| PA8641601A1 (es) | 2006-03-24 |
| EP1789402B1 (de) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5650227A2 (es) | Derivados del acido propionico utiles en desordenes lipidicos | |
| CO5580820A2 (es) | Derivados novedosos de acido (2s)-3-(4-{2-[amino]-2-oxoetoxi} fenil)-2-etoxipropanoico procesos para su preparacion y composiciones farmaceuticas que los contienen | |
| AR055060A1 (es) | Derivados de n-(piridin-2-il)-sulfonamida | |
| AR038047A1 (es) | Agentes terapeuticos | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CL2012000999A1 (es) | Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina. | |
| AR038686A1 (es) | Formulaciones de derivados de androstano y agonistas del adrenoreceptor beta 2 antiinflamatorios | |
| AR068479A1 (es) | (carboxilalquilenfenil) feniloxamidas, procedimiento para su preparacion y una coomposicion farmaceutica | |
| AR039789A1 (es) | Pirazolopiridinas sustituidas con carbamato | |
| AR068045A1 (es) | Derivados de catecolamina y prodrogas de los mismos | |
| AR043430A1 (es) | Derivados de diarilcicloalquilo, procesos para su preparacion y su uso como agentes farmaceuticos | |
| CO6501175A2 (es) | Derivados de benzotiazinas, su preparación y aplicación como fármacos | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR054551A1 (es) | Metodos para la neuroproteccion | |
| UY28896A1 (es) | Formulaciones en polvo para la inhalación , las cuales contienen beta-agonistas enantioméricamente puros | |
| UY29065A1 (es) | Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos. | |
| AR050121A1 (es) | Derivados del acido acetico con sustituyentes ciclohexilmetoxi, procesos para su preparacion y su uso como medicamentos. | |
| AR052894A1 (es) | Derivado de diazabiciclononeno | |
| AR038046A1 (es) | Derivados de acidos 3-fenil-2-arilalquiltiopropionicos moduladores de ppar alfa | |
| AR044827A1 (es) | Agentes terapeuticos derivados del acido 2-etoxi-3-fenilpropionico | |
| AR074629A1 (es) | Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2 | |
| AR039713A1 (es) | Derivados de acido benzoico orto sustituidos para el tratamiento de resistencia a la insulina | |
| UY28318A1 (es) | Derivados de diarilmetiliden piperidina, preparaciones de los mismos y sus usos | |
| AR048716A1 (es) | Derivados de acido pentenoico, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden y sus aplicaciones terapeuticas | |
| AR054795A1 (es) | Derivados de acido benzoico sustituido con alcoximetilo, procedimientos para su preparacion y su uso como medicamentos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |